The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).

P. Carson,I. Anand,Sithu Win,T. Rector,M. Haass,J. López-Sendón,Alan Miller,J. Teerlink,M. White,R. McKelvie,M. Komajda,M. Zile,J. McMurray,B. Massie
DOI: https://doi.org/10.1016/j.jchf.2014.12.017
2015-06-01
Abstract:
What problem does this paper attempt to address?